These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 3325879)
21. Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. Di Carlo E; Modesti A; Castrilli G; Landuzzi L; Allione A; de Giovanni C; Musso T; Musiani P J Pathol; 1997 May; 182(1):76-85. PubMed ID: 9227345 [TBL] [Abstract][Full Text] [Related]
22. Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts. Dennis JW; Kosh K; Bryce DM; Breitman ML Oncogene; 1989 Jul; 4(7):853-60. PubMed ID: 2666906 [TBL] [Abstract][Full Text] [Related]
23. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
24. Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection. Kerbel RS; Waghorne C; Man MS; Elliott B; Breitman ML Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1263-7. PubMed ID: 3469668 [TBL] [Abstract][Full Text] [Related]
25. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1. Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882 [TBL] [Abstract][Full Text] [Related]
26. Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene. Nielsen LL; Discafani CM; Gurnani M; Tyler RD Cancer Res; 1991 Jul; 51(14):3762-7. PubMed ID: 2065330 [TBL] [Abstract][Full Text] [Related]
27. Different metastatic potentials of ras- and src-transformed BALB/c 3T3 A31 variant cells. Tatsuka M; Ota T; Yamagishi N; Kashihara Y; Wada M; Matsuda N; Mitsui H; Seiki M; Odashima S Mol Carcinog; 1996 Apr; 15(4):300-8. PubMed ID: 8634088 [TBL] [Abstract][Full Text] [Related]
28. Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. Waghorne C; Thomas M; Lagarde A; Kerbel RS; Breitman ML Cancer Res; 1988 Nov; 48(21):6109-14. PubMed ID: 3167857 [TBL] [Abstract][Full Text] [Related]
29. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Hollmann CA; Kittrell FS; Medina D; Butel JS Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642 [TBL] [Abstract][Full Text] [Related]
30. Natural killer cell regulation of implantation and early lung growth of H-ras-transformed 10T1/2 fibroblasts in mice. Greenberg AH; Egan SE; Jarolim L; Gingras MC; Wright JA Cancer Res; 1987 Sep; 47(18):4801-5. PubMed ID: 3621176 [TBL] [Abstract][Full Text] [Related]
32. Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential. Urtreger AJ; Werbajh SE; Verrecchia F; Mauviel A; Puricelli LI; Kornblihtt AR; Bal de Kier Joffé ED Oncol Rep; 2006 Dec; 16(6):1403-10. PubMed ID: 17089068 [TBL] [Abstract][Full Text] [Related]
33. Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells. Dear TN; Ramshaw IA; Kefford RF Cancer Res; 1988 Sep; 48(18):5203-9. PubMed ID: 3136918 [TBL] [Abstract][Full Text] [Related]
34. Disordered metabolism of microfilament proteins, tropomyosin and actin, in mouse mammary epithelial cells expressing the Ha-ras oncogene. Bhattacharya B; Ciardiello F; Salomon DS; Cooper HL Oncogene Res; 1988; 3(1):51-65. PubMed ID: 3060798 [TBL] [Abstract][Full Text] [Related]
35. Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumorigenesis. Mangues R; Symmans WF; Lu S; Schwartz S; Pellicer A Oncogene; 1996 Sep; 13(5):1053-63. PubMed ID: 8806695 [TBL] [Abstract][Full Text] [Related]
36. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Itano N; Sawai T; Miyaishi O; Kimata K Cancer Res; 1999 May; 59(10):2499-504. PubMed ID: 10344764 [TBL] [Abstract][Full Text] [Related]
37. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells. Medina D; Kittrell FS; Oborn CJ; Schwartz M Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201 [TBL] [Abstract][Full Text] [Related]
38. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
39. Increased protein kinase C alpha expression in human colonic Caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes. Delage S; Chastre E; Empereur S; Wicek D; Veissiére D; Capeau J; Gespach C; Cherqui G Cancer Res; 1993 Jun; 53(12):2762-70. PubMed ID: 8504416 [TBL] [Abstract][Full Text] [Related]
40. Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells. Firon M; Shaharabany M; Altstock RT; Horev J; Abramovici A; Resau JH; Vande Woude GF; Tsarfaty I Oncogene; 2000 May; 19(20):2386-97. PubMed ID: 10828880 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]